Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
Samuel J Rae
Benzinga Contributor
About
Long term investment strategist. Author of educational and journalistic material across most financial markets and arenas. Lives in the UK.
Here's Why Valeant Is Happy To Relinquish Its European Brodalumab Rights
Why Merck And Roche Should Be Worried About DelMar Pharmaceuticals Inc.
BioZone Pharmaceuticals: Dr. Frost's Next Big Thing
Why The Smart Money Points To Spherix
Two Very Good Reasons Why Blue Calypso Stock Looks Undervalued.
A Potentially Huge Market, And A Company That Might Be Well-Placed To Take Advantage Of It.
A Biotech With Hidden Value?
